These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10468018)

  • 1. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.
    Tong P; Zografi G
    Pharm Res; 1999 Aug; 16(8):1186-92. PubMed ID: 10468018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.
    Andronis V; Zografi G
    Pharm Res; 1998 Jun; 15(6):835-42. PubMed ID: 9647347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of counterion on the phase behaviour during lyophilization of indomethacin salt forms.
    Kumar L; Baheti A; Mokashi A; Bansal AK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):136-41. PubMed ID: 21767640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
    Yoshioka M; Hancock BC; Zografi G
    J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of amorphous molecular dispersions of indomethacin and its sodium salt.
    Tong P; Zografi G
    J Pharm Sci; 2001 Dec; 90(12):1991-2004. PubMed ID: 11745758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
    Hancock BC; Shamblin SL; Zografi G
    Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of compression on non-isothermal crystallization behaviour of amorphous indomethacin.
    Ayenew Z; Paudel A; Rombaut P; Van den Mooter G
    Pharm Res; 2012 Sep; 29(9):2489-98. PubMed ID: 22638868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
    Mao C; Chamarthy SP; Pinal R
    Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.
    Lubach JW; Hau J
    Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.
    Apperley DC; Forster AH; Fournier R; Harris RK; Hodgkinson P; Lancaster RW; Rades T
    Magn Reson Chem; 2005 Nov; 43(11):881-92. PubMed ID: 16059964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
    Moura Ramos JJ; Diogo HP
    Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the viscosity of an amorphous drug using thermomechanical analysis (TMA).
    Hancock BC; Dupuis Y; Thibert R
    Pharm Res; 1999 May; 16(5):672-5. PubMed ID: 10350009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.